Antares Pharma Reports First Quarter 2016 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Antares Pharma (ATRS) Misses Q1 EPS by 2c
May 9, 2016 7:18 AM EDTAntares Pharma (NASDAQ: ATRS) reported Q1 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $11.1 million.
For earnings history and earnings-related data on Antares Pharma (ATRS) click here.
... More
